Previous benefit-risk perception studies and social experiences have clearly demonstrated that any emerging technology platform that ignores benefit-risk perception by citizens might jeopardize its public acceptability and further development. The aim of this survey was to investigate the Italian judgment on nanotechnology and which demographic and heuristic variables were most influential in shaping public perceptions of the benefits and risks of nanotechnology.

Bottini, M., Rosato, N., Gloria, F., Adanti, S., Corradino, N., Bergamaschi, A., et al. (2011). Public optimism towards nanomedicine. INTERNATIONAL JOURNAL OF NANOMEDICINE, 6, 3473-3485 [10.2147/IJN.S26340].

Public optimism towards nanomedicine

BOTTINI, MASSIMO;ROSATO, NICOLA;GLORIA, FULVIA;BERGAMASCHI, ANTONIO;MAGRINI, ANDREA
2011-01-01

Abstract

Previous benefit-risk perception studies and social experiences have clearly demonstrated that any emerging technology platform that ignores benefit-risk perception by citizens might jeopardize its public acceptability and further development. The aim of this survey was to investigate the Italian judgment on nanotechnology and which demographic and heuristic variables were most influential in shaping public perceptions of the benefits and risks of nanotechnology.
2011
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/44 - MEDICINA DEL LAVORO
English
Con Impact Factor ISI
Bottini, M., Rosato, N., Gloria, F., Adanti, S., Corradino, N., Bergamaschi, A., et al. (2011). Public optimism towards nanomedicine. INTERNATIONAL JOURNAL OF NANOMEDICINE, 6, 3473-3485 [10.2147/IJN.S26340].
Bottini, M; Rosato, N; Gloria, F; Adanti, S; Corradino, N; Bergamaschi, A; Magrini, A
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/66140
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 19
social impact